Screener
Aurinia Pharmaceuticals AUPH Other income, net
Other income, net at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 23,508 | 26,018 | 45,537 | 46,357 |
| Research and development | 13,050 | 7,432 | 20,520 | 13,175 |
| Restructuring | — | 114 | — | 1,647 |
| Other (income) expense, net | (6,234) | 9,246 | (5,955) | 13,675 |
| Total operating expenses | 36,879 | 49,925 | 73,162 | 90,543 |
| Income from operations | 46,341 | 20,083 | 87,763 | 41,930 |
| Interest income | 3,393 | 3,190 | 6,908 | 6,759 |
| Interest expense | (948) | (1,117) | (1,960) | (2,184) |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's other income, net?
- Aurinia Pharmaceuticals (AUPH) reported other income, net of $6.23M in Q2 2026.
- How has Aurinia Pharmaceuticals's other income, net changed year-over-year?
- Aurinia Pharmaceuticals's other income, net increased by 167.4% year-over-year, from -$9.25M to $6.23M.
- What is the long-term trend for Aurinia Pharmaceuticals's other income, net?
- Over 2 years (2022 to 2024), Aurinia Pharmaceuticals's other income, net has grown at a 68.9% compound annual growth rate (CAGR), from $1.52M to $4.35M.
- What does other income, net mean?
- Other income, net
Ask your AI about Aurinia Pharmaceuticals's other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude